Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
about
sameAs
Radiographic assessment of photodynamic therapy as an adjunctive treatment on induced periodontitis in immunosuppressed rats.Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levelsExenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathyAssociation of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Blood pressure, artery size, and artery compliance parallel bone size and strength in mice with differing ece1 expression.Expression and regulation of osteoprotegerin in adipose tissue.Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary DiseaseArterial calcifications.Osteoprotegerin, vascular calcification and atherosclerosis.Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children.Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses.Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.Denosumab (Prolia) Injection: A New Approach to the Treatment of Women With Postmenopausal Osteoporosis.Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.Sortase A-aided Escherichia coli expression system for functional osteoprotegerin cysteine-rich domain.Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.Characterization of the cytokine pattern of porcine bone marrow-derived cells treated with 1alpha,25(OH)D.Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot
P2860
Q33698156-2F9418A8-A1DF-4922-9AD1-7F46A4639661Q34555532-F8E88B3F-0764-47D6-92DE-F92AAC48E267Q34560277-FF29D364-DEEB-4E31-8BE8-32302ADDB89DQ34989869-1D55EB13-D646-4215-913F-033CAFCA4087Q35123561-8A92E6AF-D7D4-4D46-BEE2-5230DE62A2C7Q35742069-1CA69167-0F34-4BE1-B7FF-E48C5B14DCC1Q36860987-8BE5B9EE-C98A-4C8D-A079-4B39674DE0B6Q36995580-C47A8AED-8504-4502-AADC-0B392EB99B11Q37065591-F0435C71-53B0-4B84-8731-3E3A5B6751ACQ37126218-56E9547F-B03E-45F1-B096-0EF6C38ABD29Q37293900-778BF8A7-0DEF-4C3E-87C1-486B0CA30B79Q37310825-628AEFF0-A0E7-40D4-9E3D-4D37A404D236Q37627672-1631D91F-7B6A-44E0-9636-9BE3E6ACB3F9Q38889912-AB3B9B37-916B-4465-9A41-F0823FC84096Q41461069-5997E8D2-0DE7-4248-BA79-7138885206ABQ45238173-24B6F8C3-B1FD-4FD7-BC08-01EBFE58906EQ46025590-C9C8F761-EA13-4B25-8EC4-EE4372A57DB2Q46789871-705B9387-0F2B-4E92-BE11-5E9A9CF28FC9Q50673485-8CE0AF47-EC55-4EDF-91AD-617312A14AFEQ51497817-94F06EFE-B7D8-4466-A4DA-A57BE4E47897Q54641863-74A0B033-2FC7-4FC8-BC0C-10C6650213BCQ58803025-3A91E07D-91C5-40A9-9699-BBD7BE877637
P2860
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@ast
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@en
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@nl
type
label
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@ast
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@en
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@nl
prefLabel
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@ast
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@en
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@nl
P2093
P1476
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
@en
P2093
Sattler AM
Schaefer JR
Schoppet M
P2888
P304
P356
10.1007/S00223-003-0011-Y
P407
P577
2003-10-06T00:00:00Z
P6179
1021361757